Joint Formulary & PAD

Botulism antitoxin - Botulism type A, B and E

You are here : Home > Formulary Search > Botulism antitoxin - Botulism type A, B and E

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important
Stock not held by Surrey Trusts. Available from regional centres. Refer to TOXBASE / NPIS for advice

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Botulism antitoxin
Indication :
Botulism type A, B and E
Group Name :
Keywords :
Brand Names Include :
Important Information :

https://www.toxbase.org/

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Botulism antitoxin is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Botulism type A, B and E.

  • No records returned.